---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-081566"
form_type: "8-K"
ticker: null
cik: "0000316253"
company_name: "ENZO BIOCHEM INC"
filed_at: "2023-10-30T23:59:59+00:00"
generated_at: "2026-06-09T06:16:43.614524+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Enzo Biochem appoints Steven J. Pully as Chairman of the Board effective Oct 26, 2023

## Summary
- Steven J. Pully appointed to Board and Audit Committee; serves as Chairman.
- Receives RSU award with cash value of $100,000; 25% vests in 30 days, balance cliff vests after one year.
- Also receives cash compensation per non-employee director plan as described in prior proxy statement.
- Board adopted amended and restated bylaws enhancing procedural mechanics for shareholder nominations and Rule 14a-19.

## SEC filing metadata
- accession: 0001213900-23-081566
- form_type: 8-K
- cik: 0000316253
- company_name: ENZO BIOCHEM INC
- filed_at: 2023-10-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/316253/000121390023081566/0001213900-23-081566-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/316253/000121390023081566/ea187417-8k_enzobio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-081566
- JSON: https://secwatch.observer/filing/0001213900-23-081566.json
- Plain text: https://secwatch.observer/filing/0001213900-23-081566.txt

## Key facts
- Executive change
  Steven J. Pully was appointed as Chairman of the Board at ENZO BIOCHEM INC.
  - Action: appointed
  - Role: Chairman of the Board
  source text: On October 26, 2023, the board of directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) appointed Steven J. Pully to the Board and to the Board’s Audit Committee. Mr. Pully will serve as chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/316253/000121390023081566/0001213900-23-081566-index.htm
- Governance Changes
  ENZO BIOCHEM INC: Amended and restated bylaws to enhance procedural mechanics and make ministerial updates (effective 2023-10-26).
  - Change: bylaw amendment
  - Effective: 2023-10-26
  source text: On October 26, 2023, the Board adopted amended and restated bylaws (the “Amended and Restated Bylaws”), effective immediately. Among other things, the amendments effected by the Amended and Restated Bylaws: ● Enhance procedural mechanics, including to require additional disclosures from nominating or proposing shareholders, proposed nominees and other persons associated with nominating or proposing shareholders and to address matters relating to Rule 14a-19 and Rule 14a-8 under the Securities Exchange Act of 1934; ● Make other updates, including ministerial, clarifying, and conforming changes.
  evidence_url: https://www.sec.gov/Archives/edgar/data/316253/000121390023081566/0001213900-23-081566-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.